Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LOR | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
mRNA | PDCD4 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | THEMIS2 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | T | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
mRNA | OR2H1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
mRNA | TEC | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BCAS1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
mRNA | SLA | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PRR21 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
mRNA | EPHB6 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |